These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III. Scully MF, Kakkar VV. Biochem J; 1984 Sep 15; 222(3):571-8. PubMed ID: 6207810 [Abstract] [Full Text] [Related]
5. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides. Sie P, Ofosu F, Fernandez F, Buchanan MR, Petitou M, Boneu B. Br J Haematol; 1986 Dec 15; 64(4):707-14. PubMed ID: 2432917 [Abstract] [Full Text] [Related]
12. The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin. Buchanan MR, Boneu B, Ofosu F, Hirsh J. Blood; 1985 Jan 15; 65(1):198-201. PubMed ID: 3965047 [Abstract] [Full Text] [Related]
13. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate. Ofosu FA, Modi GJ, Blajchman MA, Buchanan MR, Johnson EA. Biochem J; 1987 Dec 15; 248(3):889-96. PubMed ID: 2963622 [Abstract] [Full Text] [Related]
17. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II. Scully MF, Ellis V, Seno N, Kakkar VV. Biochem J; 1988 Sep 01; 254(2):547-51. PubMed ID: 2902851 [Abstract] [Full Text] [Related]